Quick Summary
- Susquehanna begins IBM coverage with Neutral stance and $303 target, representing approximately 2.5% potential gain from current ~$295 level
- Quantum computing division receives $65 per share valuation, positioning IBM for exposure to projected $650B market by 2040
- Legacy mainframe and consulting operations face disruption risk from AI-powered COBOL conversion tools
- Recent quarterly results exceeded forecasts: $1.91 EPS versus $1.81 consensus, $15.92B revenue versus $15.60B projection
- Enterprise clients like Starbucks developing proprietary AI solutions creates additional revenue pressure
International Business Machines shares are hovering near $294.79, approaching the 52-week peak of $332.46 following a robust 25% second-quarter advance that pushed the stock toward all-time highs.
International Business Machines Corporation, IBM
On Friday, Susquehanna’s James Friedman launched research coverage on International Business Machines with a Neutral recommendation and $303 price objective. The target suggests modest 2.5% appreciation potential from present trading levels — hardly an aggressive bull case, though stopping short of bearish territory.
Friedman’s analysis presents a balanced perspective: significant positive attributes exist, yet insufficient catalysts warrant an immediate purchase.
The analyst expresses genuine optimism regarding IBM’s quantum computing operations. His valuation assigns $65 per share specifically to this division — an uncommon practice among equity researchers to isolate individual business unit values. Friedman projects IBM securing substantial market share within a $650 billion quantum computing industry by 2040, characterizing it as “exceptional exposure” to emerging technology.
IBM’s 52-week range spans from $212.34 to current levels, with the company commanding a $277 billion market capitalization. Year-to-date 2026 performance has underperformed the broader S&P 500, declining modestly while the benchmark index has advanced over 10%.
Consulting Division Faces Headwinds
Friedman’s caution centers primarily on IBM’s consulting business. The majority of IBM’s artificial intelligence revenue derives from lower-margin consulting services — what the analyst characterizes as “vulnerable market segment where sales dilute overall profitability.”
He additionally highlighted competitive pressure from hyperscale cloud providers integrating advanced AI capabilities directly into infrastructure agreements, potentially relegating IBM’s watsonx AI platform to specialized applications with constrained expansion potential.
The COBOL modernization challenge represents another concern. Anthropic introduced a solution this year specifically targeting legacy COBOL system transformation. Friedman interprets this development as a significant risk to IBM’s highly profitable mainframe migration and legacy system consulting revenue.
“We identify negative catalysts that consulting sector participants struggle to overcome,” Friedman noted.
Strong Quarterly Performance and Forward Outlook
IBM’s latest quarterly financial disclosure demonstrated strength. The technology giant delivered earnings per share of $1.91, surpassing the $1.81 analyst consensus, while revenue reached $15.92 billion — exceeding the $15.60 billion estimate. Top-line growth registered 9.5% on a year-over-year basis.
Regarding product developments, IBM together with Red Hat officially launched Project Lightwell, a cybersecurity solution now deployed with enterprise clients. The company also enhanced its Bob AI development platform by incorporating multi-agent functionality.
Challenges remain present. News that Starbucks is constructing internal artificial intelligence capabilities to supplant existing IBM and Microsoft software has impacted investor sentiment, fueling apprehension that major enterprise accounts may reduce external vendor reliance.
IBM’s second quarter 2026 earnings release is calendared for July 22. Wall Street consensus projects full-year earnings per share of $12.45.
Current analyst sentiment includes sixteen Buy recommendations and nine Hold ratings on IBM shares. The Street’s consensus price target stands at $306.28.



